Biofeedback Retention in Individuals With AKA
Launched by SAN JOSE STATE UNIVERSITY · Nov 8, 2021
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of biofeedback to help individuals with above-knee amputations improve their walking patterns. Biofeedback is a technique that uses wearable sensors to track the movements of patients in real-time. When patients walk, the system gives them feedback through gentle vibrations on their skin, letting them know when they reach the right movements. The goal is to see if this method can help patients learn to walk more effectively and whether those improvements last even after the training is done.
To be eligible for the study, participants must have had a leg amputation between the knee and hip at least a year ago and have experience walking with their current prosthetic leg for at least three months. They should be able to walk for at least 25 minutes with little rest and be classified as community ambulators (K2 and K3 levels). Participants can expect to undergo a single session of biofeedback training, where researchers will measure their walking ability before, during, and after the training. This research may lead to new ways for patients to continue their rehabilitation at home, making it easier for them to access care and improve their mobility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral limb amputation occurring between the knee and hip joints
- • Minimum of one-year post-amputation and should have at least three-months experience walking with their current prosthetic system.
- • Classified as K2 and K3-level community ambulators will be included in the study.
- • Able to walk a minimum of 25 minutes with minimal rest. For participants with vascular-related amputations, a doctor's note clearing them to participate in the study will be required.
- • Able to understand and speak English.
- Exclusion Criteria:
- • Previous spinal cord injury, stroke, or traumatic brain injury.
- • Major upper-limb loss, defined as an amputation occurring proximal to the wrist.
- • Previous or current injury affecting the function of their intact limb (e.g. pelvic injury, osteoarthritis, etc.)
- • Significant hip contracture exceeding 15°
- • Body-mass-index exceeding 35
About San Jose State University
San Jose State University (SJSU) is a leading public research institution located in the heart of Silicon Valley, dedicated to advancing knowledge and innovation in various fields, including health and medicine. With a strong commitment to fostering academic excellence and community engagement, SJSU conducts clinical trials that aim to contribute to the understanding of health-related issues and develop effective interventions. The university's collaborative approach brings together interdisciplinary teams of researchers, healthcare professionals, and students, ensuring rigorous methodology and ethical standards in all clinical research endeavors. Through these trials, SJSU seeks to translate research findings into practical solutions that enhance patient care and promote public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Palo Alto, California, United States
San Francisco, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials